Researchers at the University of Illinois at Chicago College of Medicine have identified a new molecular target in the process of blood clot formation, which seems to reduce clotting without excessive bleeding, the common side-effect of anti-clotting agents.
Women diagnosed with metastatic breast cancer who have also endured previous traumatic or stressful events see their cancer recur nearly twice as fast as other women, according to a report by a University of Rochester Medical Center scientist.
A new and extraordinary $22 million gift to the University of Michigan Health System is making possible a new and extraordinary institute — one with a mission of supporting fundamental research to advance the understanding of the causes, treatment and prevention of a broad range of human diseases.
A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumour fails to respond to the cutting edge therapy.
Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington’s disease – a fatal disorder for which there is currently no cure or even a treatment to slow the disease.
The European Commission has approved Exelon® patch (rivastigmine transdermal patch), an innovative way to deliver this effective medicine to patients suffering from mild to moderately severe Alzheimer’s disease.
The University of Rochester Medical Center received $1.5 million to develop a blood test for concussions by isolating proteins that can predict memory loss, chronic headaches or other neurological problems.
Hallmarks of autism are characteristic behaviors — repetitive motions, problems interacting with others, impaired communication abilities — that occur in widely different combinations and degrees of severity among those who have the condition.
A new study by the Health protection Agency estimates at least 10% of young women in England have been infected with one or more strains of the human papillomavirus (HPV) by the age of 16.
Massachusetts General Hospital (MGH) researchers have a developed a totally new approach to treating liver failure – manipulating the immune response. If the results of the animal study can be applied in human patients, the approach may be able to keep patients alive until donor organs become available or to support liver function until the organ can regenerate itself, eliminating the need for a transplant.